Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales?
Expert Rev Anticancer Ther., Jun;11(6):849-52 (2011)
Rapid, label-free, electrical whole blood bioassay based on nanobiosensor systems.
ACS Nano., Dec;5(12):9883-91 (2011)
Molecular screening for bladder cancer: progress and potential.
Nat Rev Urol., Jan;7(1):11-20 (2010)
Importance of controlling nanotube density for highly sensitive and reliable biosensors functional in physiological conditions.
ACS Nano., Nov;4(11):6914-22 (2010)
Expression profiling for bladder cancer: strategies to uncover prognostic factors.
Expert Rev Anticancer Ther., Dec;10(12):1945-54 (2010)
p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.
J. Clin. Oncol., Dec;25(34):5352-8 (2007)
Evaluation of the value of frozen tissue section used as "gold standard" for immunohistochemistry.
Am. J. Clin. Pathol., Mar;129(3):358-66 (2008)
Molecular pathogenesis and diagnostics of bladder cancer.
Annu Rev Pathol., 4:251-85 (2009)
Molecular targets and targeted therapies in bladder cancer management.
World J Urol., Feb;27(1):9-20 (2009)
Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes.
ACS Nano., May;3(5):1219-24 (2009)
A calibration method for nanowire biosensors to suppress device-to-device variation.
ACS Nano., Dec;3(12):3969-76 (2009)
Strategies for molecular expression profiling in bladder cancer.
Cancer Metastasis Rev., Dec;28(3-4):317-26 (2009)
Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer.
Clin. Cancer Res., Oct;12(20 Pt 1):5987-93 (2006)
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
J. Clin. Oncol., Dec;24(35):5552-64 (2006)
Classical pathology versus molecular pathology in renal cell carcinoma.
Curr Urol Rep., Jan;8(1):5-11 (2007)
Searching for novel therapeutics and targets: insights from clinical trials.
Urol. Oncol., 25(4):341-3 (2007)
p53 and retinoblastoma pathways in bladder cancer.
World J Urol., Dec;25(6):563-71 (2007)
Sensitivity and reproducibility of standardized-competitive RT-PCR for transcript quantification and its comparison with real time RT-PCR.
Mol. Cancer., Jan;3:5 (2004)
Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma.
J. Clin. Oncol., Mar;22(6):1007-13 (2004)
LM-PCR permits highly representative whole genome amplification of DNA isolated from small number of cells and paraffin-embedded tumor tissue sections.
Diagn. Mol. Pathol., Jun;13(2):105-15 (2004)